Co-Founders and Managing Partners
Ekokobe Fonkem, DO
Ekokobe Fonkem is a board certified neurologist and neuro-oncologist with over 18 years of cancer and neuroscience therapeutics and medical experience. His research interests are in precision oncology, neuroscience and global health.
Arnold Etame, MD – PhD
Arnold Etame is a board-certified neurological surgeon and scientist with over 20 years of cancer therapeutics research and clinical medical expertise. His research interests are precision oncology, neuroscience, and global health.
Chief Regulatory Officer
Folefac Aminkeng, PhD
Folefac Aminkeng is a Genomics, Pharmacogenomics and Precision Health Research and Translational Scientist. He has extensive experience and leadership in developing cutting-edge Genomics and Precision Health Research and Innovations and in building strategic and sustainable partnerships with academia, healthcare institutions and the industry to drive high tech genomic innovations to benefit global populations.
Chief Legal Officer
Ngosong Fonkem, JD MBA
Ngosong Fonkem is a highly experienced attorney who routinely provides strategic legal consultation to numerous domestic and foreign companies by facilitating market access for both the United States and international markets. He will be responsible for the legal strategies of Usahihi Therapeutics given his adeptness in compliance, partnership, regulatory, and international law.
Chief Medical and Clinical Operations Officer
Elias Melly, MD
Elias Melly is a board certified clinical oncologist with expertise & experience in medical oncology , radiation oncology and nuclear medicine therapeutics spanning over a decade. He is gifted in building partnerships and collaboration for impact. His research interest is in precision oncology, global health, health systems and policy.
Scientific Advisory Board
Emilia Dauway, MD
Monica Pruett